
Page 2 of 2 
 
1. Project Brief 
 
 
 
The β-lactam antibiotic, Amoxicillin, is the key API in Augmentin and Amoxil. The synthetic 
methods for obtaining amoxicillin typically involve more than 10 steps, require low-reaction 
temperatures (-30°C), and use toxic solvents (e.g. chlorinated solvents). It is reported that the 
production of one kilogram of amoxicillin generates up to about 70 kg of non-recyclable waste.  
 In recent years an enzymatic route of 
manufacture has been developed as 
replacement of the current synthetic chemical 
route to deliver more throughput and higher 
quality product, as well as coping with the 
need to reduce the cost of goods (up to 13%) 
and to improve environmental sustainability. 
In this “green process”, Hydroxyl-
phenylglycine methyl ester (HPGME) and 6-
amino penicillanic acid (6-APA) are catalysed 
by immobilised biocatalysts to form 
amoxicillin.  
  
Using the process suggested in the 
publication by Alemzadeh etal design a plant 
for the production of enzymatic amoxicillin 
with an annual throughput of 1000 metric 
tonne.   
 
In addition, design a suitable waste treatment 
plant to reduce the expected BOD/COD to 
UK legal limits.   
 
 
Alemzadeh, I., Borghei, G., Vafi, L. and Roostaazad, 
R., 2010. Enzymatic synthesis of amoxicillin with 
immobilized penicillin G acylase. Scientia Iranica. 
Transaction C, Chemistry, Chemical Engineering, 
17(1), p.106.